Page last updated: 2024-10-29

imipramine and Cardiac Death

imipramine has been researched along with Cardiac Death in 2 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
HNATKO, SI1
STIRRAT, JH1
VERCHOMIN, J1
RAMSEY, CG1
NOACK, CH1

Other Studies

2 other studies available for imipramine and Cardiac Death

ArticleYear
AGRANULOCYTOSIS ASSOCIATED WITH IMIPRAMINE (TOFRANIL).
    Canadian Medical Association journal, 1965, Jan-02, Volume: 92

    Topics: Agranulocytosis; Blood Chemical Analysis; Death; Drug Therapy; Imipramine; Leukocyte Count; Phenothi

1965
A death from overdosage of "tofranil".
    The Medical journal of Australia, 1960, Jul-30, Volume: 47(2)

    Topics: Death; Death, Sudden; Drug Overdose; Humans; Imipramine; Medical Records; Psychopharmacology

1960